Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Rajkumar

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
Leukemia|May 8, 2009
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaM Dimopoulos, E Terpos, R L Comenzo, et al.
Leukemia|January 15, 2011
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysisP Kapoor, S V Rajkumar, A Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survivalA Dispenzieri, M Q Lacy, R A Kyle, et al.
Leukemia|April 12, 2003
Thalidomide as initial therapy for early-stage myelomaS V Rajkumar, M A Gertz, M Q Lacy, et al.
Leukemia|April 7, 2011
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myelomaP Kapoor, S Kumar, S J Mandrekar, et al.
Leukemia|July 4, 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemC L H Snozek, J A Katzmann, R A Kyle, et al.
Leukemia & Lymphoma|December 28, 1999
Clinical significance of the translocation (11;14)(q13;q32) in multiple myelomaR Fonseca, J D Hoyer, P Aguayo, et al.
Leukemia|June 6, 2008
Clinical and biological significance of RAS mutations in multiple myelomaW J Chng, N Gonzalez-Paz, T Price-Troska, et al.
Leukemia|October 29, 2011
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategiesS Sinha, M A Gertz, M Q Lacy, et al.
Leukemia|March 13, 2014
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myelomaW I Gonsalves, S V Rajkumar, V Gupta, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
Leukemia|May 8, 2009
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaM Dimopoulos, E Terpos, R L Comenzo, et al.
Leukemia|January 15, 2011
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysisP Kapoor, S V Rajkumar, A Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survivalA Dispenzieri, M Q Lacy, R A Kyle, et al.
Leukemia|April 12, 2003
Thalidomide as initial therapy for early-stage myelomaS V Rajkumar, M A Gertz, M Q Lacy, et al.
Leukemia|April 7, 2011
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myelomaP Kapoor, S Kumar, S J Mandrekar, et al.
Leukemia|July 4, 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemC L H Snozek, J A Katzmann, R A Kyle, et al.
Leukemia & Lymphoma|December 28, 1999
Clinical significance of the translocation (11;14)(q13;q32) in multiple myelomaR Fonseca, J D Hoyer, P Aguayo, et al.
Leukemia|June 6, 2008
Clinical and biological significance of RAS mutations in multiple myelomaW J Chng, N Gonzalez-Paz, T Price-Troska, et al.
Leukemia|October 29, 2011
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategiesS Sinha, M A Gertz, M Q Lacy, et al.
Leukemia|March 13, 2014
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myelomaW I Gonsalves, S V Rajkumar, V Gupta, et al.
Pageof 18